Skip to main content
. 2020 Dec;10(6):1785–1794. doi: 10.21037/cdt-20-591

Table 2. Major adverse cardiac events (MACE) between the rhBNP and control groups.

MACE rhBNP group (n=135) Control group (n=136) χ2 P
Total 19 (14.07) 60 (44.12) 7.749 0.005
Acute left heart failure 8 (5.93) 23 (16.91) 6.129 0.019
Acute myocardial infarction 4 (2.96) 7 (5.15) 3.319 0.100
Malignant arrhythmia 6 (4.44) 27 (19.85) 4.022 0.021
Sudden cardiac death 1 (0.74) 3 (2.21) 2.986 0.250

Data are n (%), unless otherwise specified. rhBNP, recombinant human brain natriuretic peptide.